T-Therapeutics appoints Dr David Hung as Chairman T-Therapeutics appoints Dr David Hung as Chairman Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of TCR-based...

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis...